BioSpace News Archive

AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or the “Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announced today the development and patent filing for an enzyme-linked immunosorbent assay (ELISA)-based diagnostic test (the “Test”) for the detection of SARS‐CoV-2 neutralizing antibodies. This application marks AXIM’s fourth COVID-19 neutralizing antibody-focused pat

OrthoPediatrics Corp., a Company focused exclusively on advancing the field of pediatric orthopedics, announced that the World Pediatric Project has named OrthoPediatrics its 2020 Corporate Champion of the Year.

CANTEL MEDICAL CORP. announced the appointment of Andy Xilas to President, Cantel Dental effective January 1, 2021.

For the fifth-consecutive season, the National Football League players will raise awareness for non-profit organizations and causes on the field through the My Cause My Cleats campaign, which allows players to utilize their platform by customizing their gameday cleats to raise funds through auctions of the cleats.

Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, today announced its CEO, Maria Maccecchini, Ph.D., will present at the New York Academy of Sciences’ Alzheimer’s Disease Therapeutics: Alternatives to Amyloid 2020 Virtual Conference on Friday, December 4, 2020. Dr. Maccecchini’s presentation, “Targeting Increased Level

New investors now have the opportunity to own a share of a variety of powerful robot technologies developed by 15 companies from Denmark, Israel, Norway, Poland, Spain, Sweden and Switzerland

Highlights: The first hospitalized patient with severe COVID-19, treated under an eIND was discharged in 5 days after being treated with Silmitasertib. The first patient with moderate COVID-19 has enrolled into this clinical trial at the Center for Advanced Research and Education (CARE), Georgia . An additional study involving multiple centers in Banner -

The company’s PURE EP™ System is currently installed in six medical centers across the country Evaluation installations are growing and provide a strong foundation for commercial efforts in 2021 BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac s

Pipeline Therapeutics, a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, today announced the appointment of Julie Iwashita as the company’s Vice President of Clinical Operations. Ms. Iwashita brings more than 30 years of experience guiding global neurology and other clinical development programs through the U.S. Food and Drug Administration (FDA

sp3nw to Accelerate WSU Life Science Innovation and Entrepreneurship Into Biotech, Pharma, Diagnostics, and Medical Device Companies Through Faculty, Affiliate Expertise